
Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
Hematologic Oncology Update
00:00
Lusperisps
Lusperisps is being tried in the maloplyphum neoplasms like malofibrosis because of its anti-cytic kind of effect. There are some early reports of it being successful used there, but we'll have to wait and see on more data. Lus perisps has a negative cytokine trap, so it should help that. It's certainly worth doing except for the occasional fatigue, it's well tolerated.
Transcript
Play full episode